Wellington Shields Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.6M Buy
15,461
+8,475
+121% +$757K 0.2% 90
2026
Q1
$502K Sell
6,986
-167
-2% -$12.9K 0.08% 155
2025
Q4
$568K Hold
7,153
0.08% 145
2025
Q3
$539K Hold
7,153
0.08% 143
2025
Q2
$493K Buy
7,153
+250
+4% +$16.4K 0.08% 150
2025
Q1
$468K Sell
6,903
-2,600
-27% -$156K 0.08% 145
2024
Q4
$427K Sell
9,503
-950
-9% -$53.3K 0.08% 164
2024
Q3
$657K Buy
10,453
+500
+5% +$29.2K 0.11% 137
2024
Q2
$588K Sell
9,953
-10,499
-51% -$657K 0.11% 141
2024
Q1
$1.63M Sell
20,452
-319
-2% -$24.4K 0.31% 71
2023
Q4
$1.64M Sell
20,771
-9,699
-32% -$690K 0.2% 70
2023
Q3
$2.13M Buy
30,470
+39
+0.1% +$2.76K 0.28% 52
2023
Q2
$2.1M Hold
30,431
0.26% 55
2023
Q1
$2.26M Buy
30,431
+300
+1% +$25.2K 0.27% 48
2022
Q4
$2.81M Sell
30,131
-2,950
-9% -$285K 0.34% 42
2022
Q3
$3.15M Buy
33,081
+3,650
+12% +$361K 0.75% 27
2022
Q2
$2.73M Sell
29,431
-13,212
-31% -$1.29M 0.34% 37
2022
Q1
$4.32M Buy
42,643
+5,286
+14% +$555K 0.47% 27
2021
Q4
$3.85M Buy
37,357
+970
+3% +$89.6K 0.49% 44
2021
Q3
$3.09M Buy
36,387
+2,834
+8% +$237K 0.42% 42
2021
Q2
$2.8M Sell
33,553
-5,450
-14% -$446K 0.34% 66
2021
Q1
$2.93M Sell
39,003
-1,102
-3% -$80.3K 0.28% 76
2020
Q4
$2.74M Sell
40,105
-6,868
-15% -$447K 0.37% 57
2020
Q3
$2.74M Sell
46,973
-35,513
-43% -$2.21M 0.44% 47
2020
Q2
$5.36M Sell
82,486
-1,717
-2% -$108K 0.86% 24
2020
Q1
$5M Sell
84,203
-20,896
-20% -$1.39M 0.94% 19
2019
Q4
$7.81M Buy
105,099
+2,040
+2% +$143K 1.2% 15
2019
Q3
$6.5M Buy
103,059
+9,526
+10% +$564K 1.06% 17
2019
Q2
$5.1M Buy
93,533
+16,503
+21% +$889K 0.84% 19
2019
Q1
$4.15M Buy
77,030
+40,419
+110% +$2.49M 0.71% 22
2018
Q4
$2.4M Buy
36,611
+15,161
+71% +$1.13M 0.45% 48
2018
Q3
$1.69M Hold
21,450
0.27% 84
2018
Q2
$1.38M Sell
21,450
-400
-2% -$26.4K 0.23% 101
2018
Q1
$1.36M Sell
21,850
-40,011
-65% -$2.87M 0.21% 105
2017
Q4
$4.49M Buy
61,861
+32,662
+112% +$2.37M 0.7% 27
2017
Q3
$2.37M Buy
29,199
+6
+0% +$475 0.39% 54
2017
Q2
$2.35M Sell
29,193
-1,194
-4% -$94.3K 0.38% 58
2017
Q1
$2.38M Sell
30,387
-10,083
-25% -$805K 0.38% 55
2016
Q4
$3.19M Buy
40,470
+4,130
+11% +$334K 0.53% 41
2016
Q3
$3.23M Sell
36,340
-2,400
-6% -$227K 0.56% 38
2016
Q2
$3.71M Sell
38,740
-7,200
-16% -$718K 0.63% 34
2016
Q1
$4.76M Buy
45,940
+1,990
+5% +$193K 0.83% 18
2015
Q4
$4.3M Buy
43,950
+3,193
+8% +$313K 0.73% 23
2015
Q3
$3.93M Buy
40,757
+2,700
+7% +$284K 0.68% 27
2015
Q2
$3.99M Buy
38,057
+6,803
+22% +$695K 0.61% 35
2015
Q1
$3.23M Buy
31,254
+5,204
+20% +$527K 0.48% 44
2014
Q4
$2.51M Sell
26,050
-750
-3% -$66.1K 0.4% 52
2014
Q3
$2.13M Sell
26,800
-8,300
-24% -$654K 0.35% 56
2014
Q2
$2.65M Sell
35,100
-600
-2% -$45.3K 0.41% 42
2014
Q1
$2.67M Buy
35,700
+4,000
+13% +$283K 0.46% 36
2013
Q4
$2.27M Buy
31,700
+7,400
+30% +$475K 0.41% 46
2013
Q3
$1.38M Buy
24,300
+1,000
+4% +$59.6K 0.26% 73
2013
Q2
$1.33M Buy
+23,300
New +$1.35M 0.24% 84

Other funds holding CVS

Wellington Shields Capital Management's CVS Position: Q2 2026 in Review

Wellington Shields Capital Management increased its CVS Health (CVS) stake by 121% in Q2 2026, buying an estimated $757K and bringing the position to 15,461 shares worth $1.6M. The position accounts for 0.2% of the portfolio, ranked #90.

Wellington Shields Capital Management first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.81M in Q4 2019. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Wellington Shields Capital Management held 15,461 shares of CVS Health worth $1.6M as of Q2 2026.
  • Wellington Shields Capital Management bought 8,475 CVS Health shares in Q2 2026, an estimated $757K.
  • CVS Health made up 0.2% of Wellington Shields Capital Management's portfolio in Q2 2026, its #90 holding.
  • Wellington Shields Capital Management first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Wellington Shields Capital Management's CVS Health position peaked at $7.81M in Q4 2019.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Wellington Shields Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.